Northern Trust’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,092
| Closed | -$21K | – | 4746 |
|
|
2022
Q3 | $21K | Hold |
3,092
| – | – | ﹤0.01% | 4538 |
|
|
2022
Q2 | $33K | Hold |
3,092
| – | – | ﹤0.01% | 4532 |
|
|
2022
Q1 | $69K | Sell |
3,092
-17
| -0.5% | -$379 | ﹤0.01% | 4453 |
|
|
2021
Q4 | $88K | Hold |
3,109
| – | – | ﹤0.01% | 4463 |
|
|
2021
Q3 | $202K | Sell |
3,109
-313
| -9% | -$20.3K | ﹤0.01% | 4177 |
|
|
2021
Q2 | $273K | Sell |
3,422
-3,883
| -53% | -$310K | ﹤0.01% | 3998 |
|
|
2021
Q1 | $970K | Sell |
7,305
-747
| -9% | -$99.2K | ﹤0.01% | 3594 |
|
|
2020
Q4 | $1.28M | Sell |
8,052
-69
| -0.8% | -$11K | ﹤0.01% | 3413 |
|
|
2020
Q3 | $854K | Sell |
8,121
-416
| -5% | -$43.7K | ﹤0.01% | 3454 |
|
|
2020
Q2 | $1.03M | Buy |
8,537
+639
| +8% | +$77.4K | ﹤0.01% | 3343 |
|
|
2020
Q1 | $619K | Buy |
7,898
+680
| +9% | +$53.3K | ﹤0.01% | 3392 |
|
|
2019
Q4 | $2.13M | Sell |
7,218
-80
| -1% | -$23.6K | ﹤0.01% | 3100 |
|
|
2019
Q3 | $1.32M | Sell |
7,298
-207
| -3% | -$37.4K | ﹤0.01% | 3298 |
|
|
2019
Q2 | $2.99M | Buy |
7,505
+328
| +5% | +$131K | ﹤0.01% | 2843 |
|
|
2019
Q1 | $3.35M | Buy |
7,177
+139
| +2% | +$64.9K | ﹤0.01% | 2787 |
|
|
2018
Q4 | $3.38M | Sell |
7,038
-12
| -0.2% | -$5.77K | ﹤0.01% | 2745 |
|
|
2018
Q3 | $4.81M | Buy |
7,050
+5,148
| +271% | +$3.51M | ﹤0.01% | 2706 |
|
|
2018
Q2 | $1.3M | Buy |
+1,902
| New | +$1.3M | ﹤0.01% | 3392 |
|